Century Therapeutics (IPSC) Treasury Shares (2020 - 2022)

Century Therapeutics (IPSC) has reported Treasury Shares for 7 consecutive years, with $7.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 53.77% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (up 53.77% YoY), while the FY2025 annual figure was $5.6 million, up 97.9% from the prior year.
• Treasury Shares rose to $7.2 million in Q1 2026 per IPSC's latest filing, from $5.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $58.5 million in Q4 2022 and bottomed at $24821.0 in Q4 2024.
• Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $3.9 million in 2024.
• Annual changes were most pronounced in 2023 — Treasury Shares sank 99.92% — and 2025, when it surged 22646.69%.
• Century Therapeutics' Treasury Shares stood at $58.5 million in 2022, then tumbled by 99.92% to $49416.0 in 2023, then tumbled by 49.77% to $24821.0 in 2024, then soared by 22646.69% to $5.6 million in 2025, then climbed by 27.37% to $7.2 million in 2026.
• Business Quant data shows IPSC's Treasury Shares at $7.2 million in Q1 2026, $5.6 million in Q4 2025, and $6.6 million in Q3 2025.